Trending Now
AAVantgarde’s AAVB-039 gene therapy to treat Stargardt disease receives orphan drug status from FDA | Ophthalmology Times
Q&A: The ARCHER trial and the importance of continued GA research | Ophthalmology Times
Q&A: Frank Holz shares how innovation showcased at EURETINA brings hope for patients with GA | Ophthalmology Times
Breaking News
Surgical innovation in dry eye disease: Salivary gland transplant
Next-generation IOLs advance complex cataract care
OCT changes with low-level red light therapy for myopia in children
Alcon presenting at APACRS 2025
Breaking News
Popular Now
FDA grants breakthrough therapy designation to Nacuity’s NPI-001 for retinitis pigmentosa | Ophthalmology Times
(Image Credit: AdobeStock) The US Food and Drug Administration (FDA) has granted…
AAVantgarde’s AAVB-039 gene therapy to treat Stargardt disease receives orphan drug status from FDA | Ophthalmology Times
(Image Credit: AdobeStock/artacet) The US Food and Drug Administration (FDA) has granted…
Q&A: The ARCHER trial and the importance of continued GA research | Ophthalmology Times
(Image credit: AdobeStock/J Bettencourt) In conversation with Sydney M. Crago, Managing Editor…
Charles Miller, MD, PhD, on DME research and the initiation of the phase 2b/3 BRUNELLO trial | Ophthalmology Times
Image credit: AdobeStock/MrAshi On September 4, 2025, Merck and EyeBio announced that…
Collaborate With Us
Editor Choice
UAlbany freshman hopes to become eye doctor as tribute to mother – MSN
UAlbany freshman hopes to become eye doctor as tribute to mother MSN Source:…
EMA grants Orphan designations to MCO-010, FDA grants RMAT in Stargardt disease
(Image credit: AdobeStock/Pete) The European Medicines Agency (EMA) granted Orphan designations to…
Neurotech Appoints Peter J. McDonnell, M.D., to the Company’s Board of Directors – FinancialContent
Neurotech Appoints Peter J. McDonnell, M.D., to the Company’s Board of Directors FinancialContent…
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones – The Globe and Mail
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks…
Carl Zeiss Meditec AG Denmark Germany – AD HOC NEWS
Carl Zeiss Meditec AG Denmark Germany AD HOC NEWS Source: Author: | Date:…
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones – Laotian Times
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks…
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones – Company Announcement – FT.com – Financial Times
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks…
EyeCool Therapeutics names Dr Vance Thompson to Board – Medical Buyer
EyeCool Therapeutics names Dr Vance Thompson to Board Medical Buyer Source: Author: |…
Post-tussive Periorbital Ecchymosis in a Child Without Trauma: A Rare Neuro-Ophthalmic Presentation – Cureus
Post-tussive Periorbital Ecchymosis in a Child Without Trauma: A Rare Neuro-Ophthalmic Presentation Cureus…
Worth Reading
Meeting expectations with evolving technology
Unpacking high-yield ophthalmology tips and clinical pearls, with Nicole Bajic, MD
Possible protective role of cannabis in preventing postoperative proliferative vitreoretinopathy after retinal detachment repair
Next-generation IOLs advance complex cataract care
Subscribe Now
Enter your email address below and subscribe to our newsletter